Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial

RV Cohen; TBZ Petry; AD Miras; CM Aboud; B Johnson; TM dos Santos; CW le Roux

doi:10.2337/dc21-1192

Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial

RV Cohen
, TBZ Petry
, AD Miras
, CM Aboud
, B Johnson
, TM dos Santos
, CW le Roux

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	E177-E179
Number of pages	3
Journal	Diabetes Care
Volume	44
Issue number	10
DOIs	https://doi.org/10.2337/dc21-1192
Publication status	Published (in print/issue) - 1 Oct 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2337/dc21-1192

Cite this

Cohen, RV., Petry, TBZ., Miras, AD., Aboud, CM., Johnson, B., dos Santos, TM., & le Roux, CW. (2021). Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial. Diabetes Care, 44(10), E177-E179. https://doi.org/10.2337/dc21-1192

Cohen, RV ; Petry, TBZ ; Miras, AD et al. / Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial. In: Diabetes Care. 2021 ; Vol. 44, No. 10. pp. E177-E179.

@article{9603c28e74fe472f9e3f5a3b7e9678fd,

title = "Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial",

author = "RV Cohen and TBZ Petry and AD Miras and CM Aboud and B Johnson and \{dos Santos\}, TM and \{le Roux\}, CW",

year = "2021",

month = oct,

day = "1",

doi = "10.2337/dc21-1192",

language = "English",

volume = "44",

pages = "E177--E179",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association ",

number = "10",

}

Cohen, RV, Petry, TBZ, Miras, AD, Aboud, CM, Johnson, B, dos Santos, TM & le Roux, CW 2021, 'Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial', Diabetes Care, vol. 44, no. 10, pp. E177-E179. https://doi.org/10.2337/dc21-1192

Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial. / Cohen, RV; Petry, TBZ; Miras, AD et al.
In: Diabetes Care, Vol. 44, No. 10, 01.10.2021, p. E177-E179.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial

AU - Cohen, RV

AU - Petry, TBZ

AU - Miras, AD

AU - Aboud, CM

AU - Johnson, B

AU - dos Santos, TM

AU - le Roux, CW

PY - 2021/10/1

Y1 - 2021/10/1

U2 - 10.2337/dc21-1192

DO - 10.2337/dc21-1192

M3 - Article

C2 - 34362818

SN - 0149-5992

VL - 44

SP - E177-E179

JO - Diabetes Care

JF - Diabetes Care

IS - 10

ER -

Cohen RV, Petry TBZ, Miras AD, Aboud CM, Johnson B, dos Santos TM et al. Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial. Diabetes Care. 2021 Oct 1;44(10):E177-E179. doi: 10.2337/dc21-1192